NCT02168023View on ClinicalTrials.gov

Study to Evaluate DACC Dressings for the Prevention of Surgical Site Infections in Women Undergoing Caesarean Section.

NACompletedINTERVENTIONAL
Enrollment

543

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions
Surgical Site InfectionInfection; Cesarean Section
Interventions
DEVICE

DACC impregnated dressing

DACC impregnated dressing Sorbact Surgical Dressing ® (ABIGO Medical AB, Sweden) placed over post-caesarean wound after skin closure, the dressing will be removed after the first 48 hours postoperatively

DEVICE

Standard surgical dressing

Standard surgical dressing placed over post-caesarean wound after skin closure, the dressing will be removed after the first 48 hours postoperatively

Trial Locations (1)

03-242

Chair and Department of Obstetrics and Gynecology, II Faculty of Medicine, Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER

NCT02168023 - Study to Evaluate DACC Dressings for the Prevention of Surgical Site Infections in Women Undergoing Caesarean Section. | Biotech Hunter | Biotech Hunter